We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.
An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)
Bleyer, A, Welch, HG (2012). Effect of three decades of screening mammography on breast-cancer incidence. The New England Journal of Medicine367, 1998–2005.CrossRefGoogle ScholarPubMed
Hippisley-Cox, J, Coupland, C (2010). Unintended effects of statins in men and women in England and Wales: population based cohort study using the QResearch database. British Medical Journal340, c2197.CrossRefGoogle ScholarPubMed
Lunchtime Debate (2010). International Early Psychosis Association Conference, Amsterdam, 29 November 2010.Google Scholar
Mossaheb, N. Personal correspondence. June 2013.Google Scholar
Nelson, B. Personal correspondence. June 2013.Google Scholar
Nelson, B, Yung, A (2011). Should a risk syndrome for psychosis be included in DSM-5?Current Opinion in Psychiatry24, 128–133.CrossRefGoogle ScholarPubMed
Taylor, F, Ward, K, Moore, TH, Burke, M, Davey Smith, G, Casas, JP, Ebrahim, S. (2011). Cochrane Database Syst Rev. Issue 1: Art. No.:CD004816. (doi: 10.1002/14651858.CD004816.pub4) Statins for the primary prevention of cardiovascular disease.Google Scholar
Woods, SW, Walsh, BC, Saksa, JR, McGlashan, TH (2010). The case for including attenuated psychotic symptoms syndrome in DSM-5 as a psychosis risk syndrome. Schizophrenia Research123, 199–207.CrossRefGoogle ScholarPubMed